{"title":"利用总统防治艾滋病紧急救援计划和全球基金支持的实验室网络进行综合疾病检测：尼日利亚综合检测艾滋病毒、结核病和COVID-19的经验教训。","authors":"McPaul Okoye,Catherine Okoi,Nicole Espy,Nwando Mba,Celestina Obiekea,Anthony Ahumibe,Kingsley Madubuike,Nnaemeka Ndodo,Innocent Okoli,Kingsley Njoku,Chibuzor Eneh,Afolabi Akinpelu,Olajumoke Babatunde,Philippe Chebu,Christopher Chime,Nnaemeka C Iriemenam,Clement Zeh,Patricia Hall-Edison,Obinna Nnadozie,Israel Audu,Victor Obianeri,Chika Onwuamah,Aminu Suleiman,Jibrin Kama,Catherine Godfrey,Chinyere Okolo,Emmanuel Agogo,Dhamari Naidoo,Chidozie Ezechukwu,Akudo Ikpeazu,Chukwuma Anyaike,Mahesh Swaminathan,Mary Boyd,Ifedayo Adetifa,Chikwe Ihekweazu","doi":"10.1093/infdis/jiaf334","DOIUrl":null,"url":null,"abstract":"The Nigeria Centre for Disease Control and Prevention, as part of the strategic approach to the COVID-19 outbreak response in Nigeria, coordinated the implementation of an integrated disease testing (IDT) strategy with support from multiple partners. This involved adaptation of existing US President's Emergency Plan for AIDS Relief (PEPFAR)- and Global Fund-supported molecular laboratory networks and integration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into these. This enabled the country to provide large-scale testing and rapid return of results for SARS-CoV-2 from 2020 to 2022. IDT provided an opportunity for mainstreaming outbreak response into existing human immunodeficiency virus (HIV) and tuberculosis testing laboratories. Lessons learned from this have informed the adoption of IDT across the country laboratory network as an efficient approach to multiple disease testing and pandemic preparedness and response in Nigeria.","PeriodicalId":501010,"journal":{"name":"The Journal of Infectious Diseases","volume":"56 1","pages":"S150-S154"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Leveraging PEPFAR- and Global Fund-Supported Laboratory Network for Integrated Disease Testing: Lessons From Integrated HIV, Tuberculosis, and COVID-19 Testing in Nigeria.\",\"authors\":\"McPaul Okoye,Catherine Okoi,Nicole Espy,Nwando Mba,Celestina Obiekea,Anthony Ahumibe,Kingsley Madubuike,Nnaemeka Ndodo,Innocent Okoli,Kingsley Njoku,Chibuzor Eneh,Afolabi Akinpelu,Olajumoke Babatunde,Philippe Chebu,Christopher Chime,Nnaemeka C Iriemenam,Clement Zeh,Patricia Hall-Edison,Obinna Nnadozie,Israel Audu,Victor Obianeri,Chika Onwuamah,Aminu Suleiman,Jibrin Kama,Catherine Godfrey,Chinyere Okolo,Emmanuel Agogo,Dhamari Naidoo,Chidozie Ezechukwu,Akudo Ikpeazu,Chukwuma Anyaike,Mahesh Swaminathan,Mary Boyd,Ifedayo Adetifa,Chikwe Ihekweazu\",\"doi\":\"10.1093/infdis/jiaf334\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Nigeria Centre for Disease Control and Prevention, as part of the strategic approach to the COVID-19 outbreak response in Nigeria, coordinated the implementation of an integrated disease testing (IDT) strategy with support from multiple partners. This involved adaptation of existing US President's Emergency Plan for AIDS Relief (PEPFAR)- and Global Fund-supported molecular laboratory networks and integration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into these. This enabled the country to provide large-scale testing and rapid return of results for SARS-CoV-2 from 2020 to 2022. IDT provided an opportunity for mainstreaming outbreak response into existing human immunodeficiency virus (HIV) and tuberculosis testing laboratories. Lessons learned from this have informed the adoption of IDT across the country laboratory network as an efficient approach to multiple disease testing and pandemic preparedness and response in Nigeria.\",\"PeriodicalId\":501010,\"journal\":{\"name\":\"The Journal of Infectious Diseases\",\"volume\":\"56 1\",\"pages\":\"S150-S154\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/infdis/jiaf334\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/infdis/jiaf334","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Leveraging PEPFAR- and Global Fund-Supported Laboratory Network for Integrated Disease Testing: Lessons From Integrated HIV, Tuberculosis, and COVID-19 Testing in Nigeria.
The Nigeria Centre for Disease Control and Prevention, as part of the strategic approach to the COVID-19 outbreak response in Nigeria, coordinated the implementation of an integrated disease testing (IDT) strategy with support from multiple partners. This involved adaptation of existing US President's Emergency Plan for AIDS Relief (PEPFAR)- and Global Fund-supported molecular laboratory networks and integration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into these. This enabled the country to provide large-scale testing and rapid return of results for SARS-CoV-2 from 2020 to 2022. IDT provided an opportunity for mainstreaming outbreak response into existing human immunodeficiency virus (HIV) and tuberculosis testing laboratories. Lessons learned from this have informed the adoption of IDT across the country laboratory network as an efficient approach to multiple disease testing and pandemic preparedness and response in Nigeria.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
